Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: Provider Knowledge and Acceptability
Lucy Paintain(University of London), Jayne Webster(London School of Hygiene & Tropical Medicine), Daniel Chandramohan(London School of Hygiene & Tropical Medicine), Brian Greenwood(London School of Hygiene & Tropical Medicine), Harry Tagbor(University of Health and Allied Sciences), Rose Odotei Adjei(Kwame Nkrumah University of Science and Technology), Caroline Jones(The University of Western Australia), Nana A Afrah(Kwame Nkrumah University of Science and Technology), Esther Ekua Amoako(Kwame Nkrumah University of Science and Technology), Gifty Antwi(Kwame Nkrumah University of Science and Technology)
Cited by 37
Related Papers
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
|New England Journal of Medicine|1995|439
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345
Heterozygote advantage for HLA class-II type in hepatitis B virus infection
|Nature Genetics|1997|319